Decision support for clinical flow

Increased efficiency and quality for hemato-oncology labs

hema.to is the world's first software service to provide end-to-end decision support: from raw flow files to a diagnostic report.

Increase efficiency - maintain quality

Maintain quality

As a user, you have full control over the extent of decision support you employ: for each case, the exact confidence hema.to has in its diagnostic recommendation is made transparent.

Cut time to diagnosis

Whether it's gating or drawing one's conclusion: high-quality diagnoses take time. hema.to recommends diagnoses in seconds, reducing time to diagnosis to increase your throughput.

Export-ready reports

Writing medical reports can be tedious. hema.to can explain the clinical reasoning behind a diagnosis, so that you can configure, adapt and export medical reports in seconds.

When hema.to is right for you

You want to increase standardization of flow analyses
You carry out more than 1,000 clinical flow analyses annually
You have difficulty finding qualified personnel
You want to increase diagnostic throughput

Demonstrated quality

Medical software requires development processes that meet the highest standards. hema.to is a CE-IVD product and is scientifically backed by peer-reviewed publications.

IVDD compliant

We are compliant with the In Vitro Diagnostic Directive (IVDD), meaning that we conform to ISO 13485 (quality management), ISO 14971 (risk management), ISO 62366 (usability), ISO 62304 (software life-cycle management) and IEC 82304 (health software).

Clinically proven

We have demonstrated expert-level performance at making differential diagnoses between the most common B-NHL types and healthy patients. Our mean accuracy was > 99% in a trial with >4k cases. Human intervention would have been unnecessary in more than 75% of cases (trial publication).

GDPR compliant

Our application performs client-side anonymization, which means that your patient's name never even reaches our servers.

Scientifically backed

In a series of papers (Cell Patterns, Cytometry A, ASH blood I, ASH blood II), we have demonstrated that our core AI algorithms are capable of hematologist-level B-NHL classifications, and that this knowledge can be transfered across different flow protocols.

hema.to in figures

>4k
number of diagnoses supported by hema.to
99.7 %
mean accuracy
>75 %
of cases potentially required no human intervention
4
peer-reviewed publications
Testimonials

hema.to in quotes

The world's largest laboratory networks trust hema.to to improve their workflows

“Nobody integrates as much data as hema.to.“

Dr. med. Richard Schabath
Helios hematologist (OA), founder of a hematological practice

“In the long run, there will be only three specialized hematology labs in the Netherlands — I think that hema.to will help us to be amongst them.“

Dr. Jürgen Riedl
Hematologist & Co-founder of Result Laboratorium

“hema.to's quantitative diagnosis is revolutionary.“

Dr. Cassano Juan Carlos
Zentrum für Labormedizin

trusted by

Contact

Get in touch

We will not share your data with any third parties.

Your message has been submitted. We will get back to you within 24-48 hours.
Oops! Something went wrong.